The continuous tightening of drug supervision is accelerating the transformation and upgrading of pharmaceutical companies

Recently, Gansu Province issued the "Measures for Comprehensively Strengthening the Capacity Building of Drug Supervision and Promoting the High-Quality Development of the Pharmaceutical Industry", from strengthening the construction of organizational guarantee capacity, strengthening the construction of law enforcement supervision capacity, strengthening the construction of review and approval capacity, and strengthening the capacity of risk prevention and control.
19 measures have been proposed in six aspects: construction, strengthening of technical support capacity building, and strengthening of service development capacity building, to promote the high-quality development of the pharmaceutical industry
.
The continuous tightening of drug supervision is accelerating the transformation and upgrading of pharmaceutical companies (picture source: Pharmaceutical Network) It is worth noting that in addition to Gansu Province, many other places have recently begun to publish announcements that are in line with their own development and can strengthen drug supervision capabilities.
Related documents
.
In this regard, the industry believes that drug safety is a people’s livelihood project and a people’s heart project; at present, all localities have successively issued documents to strengthen the construction of drug supervision capabilities and promote the high-quality development of the pharmaceutical industry.
The pharmaceutical industry is facing more stringent standards and stricter standards.
Supervision, stricter penalties, and more serious accountability have become the general trend
.
In this context, the industry predicts that many companies in the pharmaceutical industry will face major challenges in the future, and some companies that cannot meet the requirements may be eliminated at an accelerated pace
.
For pharmaceutical companies, how to better ensure the safety of medicines, standardization and healthy development has become a top priority in the context of continuous stricter supervision and promotion of the high-quality development of the pharmaceutical industry
.
So what should pharmaceutical companies respond to? Analysts said that in recent years, with the release of a series of medical reform documents and the continuous tightening of industry supervision, pharmaceutical companies have already begun to respond to more changes in the industry by accelerating transformation and upgrading
.
It is understood that, first of all, for the development of compliance, in the production management link, pharmaceutical companies are still upgrading their management systems while strictly implementing the requirements of laws, regulations and technical standards
.
For example, in terms of daily management, many pharmaceutical companies have refined the management system and formulated rigorous review procedures; and periodically analyzed the problems in the development and proposed corrective measures
.
In addition, in order to promote the high-quality development of the pharmaceutical industry, pharmaceutical companies are still vigorously innovating
.
It is reported that in recent years, the innovation and R&D investment of local pharmaceutical companies has been continuously increasing
.
Statistics show that R&D investment of large-scale enterprises has increased by about 8% annually.
In 2020, R&D expenses of listed companies will account for more than 6% of sales revenue
.
There are also data showing that the R&D investment of innovative drug industry chain companies in the third quarter of 2021 increased by more than 30% year-on-year, reaching 20.
996 billion yuan
.
In this context, domestic pharmaceutical companies are expected to usher in a "big wind" of innovation, and the space for development may also continue to expand
.
In addition, in order to better ensure production safety and achieve their own high-quality development, many companies are currently accelerating the elimination of technologically backward equipment, and at the same time introducing and applying current mature automation, intelligence, information and other new technologies to In terms of equipment, gradually improve the implementation of electromechanical integration of pharmaceutical production equipment, so that the production process is unmanned, so as to improve production efficiency and ensure the stability of the quality of the drugs produced
.
It is worth mentioning that in order to meet the transformation and upgrading requirements of pharmaceutical companies, many pharmaceutical equipment companies are still building smart pharmaceutical factories to achieve flexible pharmaceutical manufacturing, full-cycle information management of pharmaceuticals, continuous optimization of process parameters, and consistent products.
Performance evaluation; and better guarantee the integrity of data, improve the overall efficiency of the pharmaceutical industry, and ensure the compliance of the production process
.
For example, Chutian Technology has been actively promoting the development of pharmaceutical intelligent manufacturing in recent years
.
On April 28, 2020, the fourth phase of the project has officially started construction.
The project includes Chutian Science and Technology Innovation Center Building, Talent Center Building, Central Workshop, Intelligent Backpack Workshop, Intelligent Chinese Medicine Workshop and other R&D, manufacturing and management units.
Modern building
.
Among them, the smart packaging workshop has been put into production, and the entire project is scheduled to be completed in the first half of 2022
.
In general, under the background of accelerated transformation and upgrading of pharmaceutical companies, in order to better meet the high-quality development needs of modern pharmaceutical companies, the design and development concepts of the pharmaceutical equipment industry have also begun to advance with the times
.
In the future, with the continuous development of the pharmaceutical market, pharmaceutical machinery companies will continue to advance their innovative development in order to meet more market demands
.